Mana.bio is an AI based drug delivery startup, focusing on gene therapy including RNA and DNA-based therapeutics and vaccines
Employees: 11-50
Total raised: $19.5M
Investors 2
| Date | Name | Website |
| 25.03.2022 | LionBird | lionbird.c... |
| 26.02.2022 | NFX | nfx.com |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 12.10.2023 | Seed | $19.5M | - |
Mentions in press and media 5
| Date | Title | Description |
| 06.05.2026 | - | Strategic Leadership Additions Mana.bio announced the appointment of Thaminda Ramanayake as a member of its board of directors, Michelle Lynn Hall as a board observer, and Guy Van Meter as strategic advisor. These additions bring deep exper... |
| 12.10.2023 | Israeli biotech startup Mana.bio launches AI-fueled programmable drug therapy | Israeli biotech startup Mana.bio has been planning to launch its programmable drug treatment solution for months, and decided to forge ahead in spite of the attacks that happened this past weekend in the country. The company is employing AI... |
| 12.10.2023 | Mana.bio Raises $19.5M in Seed Financing | Mana.bio, a Tel Aviv, Israel-based biotechnology company accelerating programmable drug delivery, raised $19.5M in seed financing. The round was co-led by Andreessen Horowitz Bio + Health, Base4 Capital, NFX, LionBird and Technion Institute... |
| 14.06.2022 | От BioTech к TechBio: как меняется сфера биотехнологий | Биология — одна из самых развитых технологий на Земле. Представьте сотовый телефон, который может расти, воспроизводиться и чинить себя. Именно это умеют делать клетки каждого организма — от бактерии до гигантской секвойи. Современные проры... |
| - | Mana.bio | “Mana.bio is an AI based drug delivery startup, focusing on gene therapy including RNA and DNA-based therapeutics and vaccines” |